125 related articles for article (PubMed ID: 20224859)
1. Prognostic value of histological and immunohistochemical characteristics for predicting the recurrence of medullary thyroid carcinoma.
Ríos A; Rodríguez JM; Acosta JM; Balsalobre MD; Torregrosa N; Sola J; Pérez-Flores D; Parrilla P
Ann Surg Oncol; 2010 Sep; 17(9):2444-51. PubMed ID: 20224859
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
3. Cytologic diagnosis of recurrent medullary thyroid carcinoma with oncocytic change twenty-one years post-thyroidectomy: case report and review of the literature.
Tranchida P; Estigarribia J; Sethi S; Giorgadze T
Diagn Cytopathol; 2011 Sep; 39(9):641-6. PubMed ID: 20949456
[TBL] [Abstract][Full Text] [Related]
4. Medullary carcinoma of the thyroid with serotonin production and carcinoid-like syndrome.
Hocevar M; Bergant D; Auersperg M; Golouh R
Eur J Surg Oncol; 2001 Mar; 27(2):219-22. PubMed ID: 11289766
[No Abstract] [Full Text] [Related]
5. [Medullary carcinoma of the thyroid. A clinical case].
Faccini M; Caputo P; Gavezzoli D; Bonandrini L
Minerva Chir; 1999; 54(1-2):79-81. PubMed ID: 10230232
[TBL] [Abstract][Full Text] [Related]
6. [Micromedullary thyroid carcinoma: school experience].
Palermo S; Di Matteo FM; Savino G; Di Marco C; Catania A; De Antoni E
G Chir; 2010; 31(6-7):299-302. PubMed ID: 20646376
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
[TBL] [Abstract][Full Text] [Related]
8. [Medullary thyroid carcinoma--familial or sporadic disease?].
Høie J; Jørgensen OG; Nesland JM; Møller P; Bjøro K
Tidsskr Nor Laegeforen; 1994 Oct; 114(25):2951-4. PubMed ID: 7974404
[TBL] [Abstract][Full Text] [Related]
9. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland].
Krassowski J; Słowińska-Srzednicka J; Gietka M; Sawicki A; Kokot F; Zgliczyński S
Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):757-9. PubMed ID: 2641802
[No Abstract] [Full Text] [Related]
11. [Medullary carcinoma of the thyroid: a clinical contribution].
Angeli G; Brazzarola P; Bottura D; Bonomo S; Castellini C; Moser A; Vicenzi L; Mazzola F; Rizzo S; Betresini B; Ballarin A; Rosa G
Chir Ital; 2002; 54(1):25-9. PubMed ID: 11942005
[TBL] [Abstract][Full Text] [Related]
12. [Medullary carcinoma of the thyroid. A report of 4 clinical cases and a review of the literature].
Russo F; Spina C; Arturi A; Rulli F; Barone Adesi TL; Gentileschi P; Forlini A
Minerva Chir; 1997 Apr; 52(4):475-84. PubMed ID: 9265135
[TBL] [Abstract][Full Text] [Related]
13. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
14. Current management of medullary thyroid cancer.
Milan SA; Sosa JA; Roman SA
Minerva Chir; 2010 Feb; 65(1):27-37. PubMed ID: 20212415
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma: state of the art.
Favia G; Iacobone M
G Chir; 2005; 26(11-12):405-9. PubMed ID: 16472416
[TBL] [Abstract][Full Text] [Related]
16. [Management of lymph node metastases in well-differentiated and medullary thyroid cancer: retrospective study on 52 cases].
Antonelli AR; Piazza C; Lombardi D; Casigli F
Ann Ital Chir; 2004; 75(3):305-14. PubMed ID: 15605518
[TBL] [Abstract][Full Text] [Related]
17. Re-operation for recurrent lymph node metastasis of medullary thyroid cancer--is it useful?
Vriens B; Van Hee R
Acta Chir Belg; 2007 Jun; 107(3):331-5. PubMed ID: 17685266
[TBL] [Abstract][Full Text] [Related]
18. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
Machens A; Hauptmann S; Dralle H
Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
[TBL] [Abstract][Full Text] [Related]
19. Argyrophilia and chromogranin A and B immunostaining in patients with sporadic medullary thyroid carcinoma. A critical appraisal of their prognostic utility.
Scopsi L; Sampietro G; Boracchi P; Collini P
J Pathol; 1998 Apr; 184(4):414-9. PubMed ID: 9664908
[TBL] [Abstract][Full Text] [Related]
20. Thyroidectomy for medullary carcinoma in MEN 2A: positive genetic screening as the sole indicator for surgery.
McNally D; Campbell WJ; Sloan JM; Morrison PJ; Russell CF
Ulster Med J; 1997 Nov; 66(2):134-5. PubMed ID: 9414944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
